HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An infant with acrodermatitis continua of Hallopeau: successful treatment with thalidomide and UVB therapy.

Abstract
Acrodermatitis Continua of Hallopeau is a rare, chronic, recurrent disorder classified as a form of pustular psoriasis, and most cases affect one or two digits. It tends to be resistant to both topical and systemic treatments for psoriasis. We present an infant with Acrodermatitis Continua of Hallopeau affecting nineteen nails, with an excellent response to the combination of thalidomide and ultraviolet B phototherapy.
AuthorsAna Elisa Kiszewski, Damiê De Villa, Ilóite Scheibel, Nelson Ricachnevsky
JournalPediatric dermatology (Pediatr Dermatol) 2009 Jan-Feb Vol. 26 Issue 1 Pg. 105-6 ISSN: 1525-1470 [Electronic] United States
PMID19250426 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Thalidomide
Topics
  • Acrodermatitis (drug therapy, radiotherapy)
  • Child, Preschool
  • Combined Modality Therapy
  • Foot Dermatoses (drug therapy, radiotherapy)
  • Hand Dermatoses (drug therapy, radiotherapy)
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Infant
  • Male
  • Psoriasis (drug therapy, radiotherapy)
  • Thalidomide (administration & dosage)
  • Ultraviolet Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: